The Topical Absorbable Hemostats Market Size is valued at 492.2 Million in 2022 and is predicted to reach 970.3 Million by the year 2031 at a 7.90 % CAGR during the forecast period for 2023-2031.
Increasing number of trauma and surgical procedures where only hemostatic agents can be used to manage bleeding is expected to drive the global topical hemostats market near the future. Topical absorbable hemostats including collagen, polysaccharide, gelatin, oxidized regenerated cellulose and combination hemostats comprises of an absorbable sponge, foam, pad and other material with a topical hemostatic agent used to apply on bleeding site. These products also used in surgical specialty procedures.
The Market of Topical Absorbable Hemostats is projected to witness lucrative growth over the forecast period owing to increase in demand supported by rising surgery volumes. Additionally, increasing prevalence of chronic conditions and increasing geriatric population are driving the growth of market. For instance, according to Centers for Disease Control and Prevention (CDC) statistics, more than 45% of American population suffers from at least one chronic condition requiring critical care. Moreover, companies are investing on research and development expected to fuel the growth of market. For instance, Ethicon, LLC has ongoing clinical trial intended to study for surgical powder moderate parenchymal or soft tissue intraoperative bleeding.
Market Segmentation
The Global Topical Absorbable Hemostats market is segmented on the basis of product and region. Based on the products, the market is divided into combination hemostats – pads, oxidized regenerated cellulose-based hemostats, polysaccharide-based hemostats, gelatin-based hemostats, collagen-based hemostats and others. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that Europe held the largest share of the market, followed by America and Asia Pacific. On the other hand, North America is expected to dominate the market during the analysis of forecast period.
Competitive Landscape
Some of The Key Players in The Topical Absorbable Hemostats Market:
- Baxter
- R. Bard
- Ethicon
- Gelita AG
- Pfizer
- Braun Melsungen AG
- Teleflex Incorporated.
- 3-D Matrix Ltd
- Angiotech Pharmaceuticals Inc
- Anika Therapeutics Inc
- APRUS Bio-Medical Innovations Pvt Ltd
- Arch Therapeutics Inc
- Cellphire Inc
- Covalon Technologies Ltd
- Cresilon Inc
- Endomedix Incorporated
- Entegrion Inc
- ETX Pharma Inc
- Gamma Therapeutics Inc
- GATT Technologies BV
- gel-e Inc
- Haemostatix Ltd
- Hemostasis LLC
- HLL Lifecare Ltd
- Keratin Biosciences Inc
- Leader Biomedical Europe BV
- LifeBond Ltd
- Protege Biomedical
- Resorba GmbH
- Sanara MedTech Inc
- Sanofi Biosurgery Inc
- Sea Run Holdings Inc
- Therus Corporation
- Thrombotargets Corp
- United Health Products, Inc.
- Xcede Technologies Inc
- Other Prominent Players
The Topical Absorbable Hemostats Market Report Scope
Report Attribute |
Specifications |
Market Size Value In 2022 |
USD 492.2 Million |
Revenue Forecast In 2031 |
USD 970.3 Million |
Growth Rate CAGR |
CAGR of 7.90 % from 2023 to 2031 |
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
Historic Year |
2019 to 2022 |
Forecast Year |
2023-2031 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
By Product |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
Competitive Landscape |
3-D Matrix Ltd, Angiotech Pharmaceuticals Inc, Anika Therapeutics Inc, APRUS Bio-Medical Innovations Pvt Ltd, Arch Therapeutics Inc, Baxter, C.R. Bard, Cellphire Inc, Covalon Technologies Ltd, Cresilon Inc, Endomedix Incorporated, Entegrion Inc, Ethicon, ETX Pharma Inc, Gamma Therapeutics Inc, GATT Technologies BV, gel-e Inc, Gelita, Haemostatix Ltd, Hemostasis LLC, HLL Lifecare Ltd, Keratin Biosciences Inc, Leader Biomedical Europe BV, LifeBond Ltd, Mallinckrodt Pharmaceuticals, Mochida Pharmaceutical Co., Ltd., Pfizer, Protege Biomedical, Resorba GmbH, Sanara MedTech Inc, Sanofi Biosurgery Inc, Sea Run Holdings Inc, Teleflex, Therus Corporation, Thrombotargets Corp, United Health Products, Inc., Xcede Technologies Inc, Z-Medica llc and Integra LifeSciences |
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |